Showing 1 - 10 results of 10 for search 'Douglas B Evans', query time: 0.04s
Refine Results
-
1
-
2
-
3
ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma. by Michael P Kim, Jason B Fleming, Huamin Wang, James L Abbruzzese, Woonyoung Choi, Scott Kopetz, David J McConkey, Douglas B Evans, Gary E Gallick
Published 2011-01-01
Article -
4
Interpreting Sequence Variation in PDAC-Predisposing Genes Using a Multi-Tier Annotation Approach Performed at the Gene, Patient, and Cohort Level by Michael T. Zimmermann, Michael T. Zimmermann, Michael T. Zimmermann, Angela J. Mathison, Angela J. Mathison, Tim Stodola, Douglas B. Evans, Douglas B. Evans, Jenica L. Abrudan, Wendy Demos, Michael Tschannen, Mohammed Aldakkak, Jennifer Geurts, Jennifer Geurts, Gwen Lomberk, Gwen Lomberk, Gwen Lomberk, Gwen Lomberk, Susan Tsai, Susan Tsai, Susan Tsai, Raul Urrutia, Raul Urrutia, Raul Urrutia, Raul Urrutia
Published 2021-03-01
Article -
5
Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models by Susan Tsai, Laura McOlash, Katie Palen, Bryon Johnson, Christine Duris, Qiuhui Yang, Michael B. Dwinell, Bryan Hunt, Douglas B. Evans, Jill Gershan, Michael A. James
Published 2018-03-01
Article -
6
DGKζ exerts greater control than DGKα over CD8+ T cell activity and tumor inhibition by Junchen Gu, Cindy Wang, Carolyn Cao, Jinwen Huang, Sandra Holzhauer, Heshani Desilva, Erin M. Wesley, Douglas B. Evans, Joseph Benci, Michael Wichroski, Susan Wee, Matthew J. Riese
Published 2021-01-01
Article -
7
Value of Pretreatment 18F-fluorodeoxyglucose Positron Emission Tomography in Patients With Localized Pancreatic Cancer Treated With Neoadjuvant Therapy by Chad A. Barnes, Mohammed Aldakkak, Callisia N. Clarke, Kathleen K. Christians, Daniel Bucklan, Michael Holt, Parag Tolat, Paul S. Ritch, Ben George, William A. Hall, Beth A. Erickson, Douglas B. Evans, Susan Tsai
Published 2020-04-01
Article -
8
Chemotherapy-free treatment targeting fusions and driver mutations in wild-type pancreatic ductal adenocarcinoma, a case series by Maahum Mehdi, Aniko Szabo, Aditya Shreenivas, James P. Thomas, Susan Tsai, Kathleen K. Christians, Douglas B. Evans, Callisia N. Clarke, William A. Hall, Beth Erickson, Gulrayz Ahmed, Bicky Thapa, Thomas McFall, Ben George, Razelle Kurzrock, Mandana Kamgar
Published 2024-05-01
Article -
9
Impact of Neoadjuvant Chemoradiation on Pathologic Response in Patients With Localized Pancreatic Cancer by David Wittmann, William A. Hall, Kathleen K. Christians, Chad A. Barnes, Neil R. Jariwalla, Mohammed Aldakkak, Callisia N. Clarke, Ben George, Paul S. Ritch, Matthew Riese, Abdul H. Khan, Naveen Kulkarni, John Evans, Beth A. Erickson, Douglas B. Evans, Susan Tsai
Published 2020-04-01
Article -
10
Characterization of an oligometastatic state in patients with metastatic pancreatic adenocarcinoma undergoing systemic chemotherapy by Saryleine deOrtiz de Choudens, Alexis Visotcky, Anjishnu Banerjee, Mohammed Aldakkak, Susan Tsai, Douglas B. Evans, Kathleen K. Christians, Callisia N. Clarke, Ben George, Aditya Shreenivas, Mandana Kamgar, Sakti Chakrabarti, Kulwinder S. Dua, Abdul Haq Khan, Srivats Madhavan, Beth A. Erickson, William A. Hall
Published 2024-01-01
Article